Microcrystalline Cellulose as a Versatile Excipient in Drug Research

Microcrystalline cellulose (MCC) has emerged as the most resourceful excipient of all times in drug research. Thanks to its profusion in terms of grades available for different needs and its physical properties that support a variety of functionality requirements especially for the most frequently used unit dosage forms. MCC can be used as a bulking agent, disintegrant, binder, lubricant, and glidant besides being a stability enhancer and a secondary suspending agent. It can be used in direct compression of most drugs and saves material, capital, equipment, and labor. Its ever increasing applications in drug research include its utility in immediate release (tablets and liquids) dosage forms, sustained release dosage forms (multiparticulates and matrix tablets), topical preparations, oral liquids, organoleptic enhancements as in chewable and mouth dissolving tablets, anti-res ux, and nutraceuticals. The review discusses these applications in sufÞ cient detail citing examples and investigating the justiÞ cations for such functions. Key words: Avicel, direct compression, extrusion, microcrystalline cellulose, multiparticulates, wet granulation.

[1]  Kenneth C. Waterman,et al.  Press-coating of immediate release powders onto coated controlled release tablets with adhesives. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Bernard Bataille,et al.  Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronization , 1995 .

[3]  James W McGinity,et al.  Production of spherical pellets by a hot-melt extrusion and spheronization process. , 2002, International journal of pharmaceutics.

[4]  Fridrun Podczeck,et al.  Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization , 1995 .

[5]  S. Saha,et al.  Multifunctional coprocessed excipients for improved tabletting performance , 2009 .

[6]  The influence of type and quantity of model drug on the extrusion/spheronization of mixtures with microcrystalline cellulose. I. Extrusion parameters. , 2001, International journal of pharmaceutics.

[7]  Maribel Rios Debating excipient functionality , 2006 .

[8]  L. Augsburger,et al.  Evaluation of the plug formation process of silicified microcrystalline cellulose. , 2002, International journal of pharmaceutics.

[9]  Michael D. Tousey The Granulation Process 101 Basic Technologies for Tablet Making , 2002 .

[10]  C. Liew,et al.  Torque rheological parameters to predict pellet quality in extrusion-spheronization. , 2006, International journal of pharmaceutics.

[11]  J. Sousa,et al.  Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. , 2002, International journal of pharmaceutics.

[12]  P. Deasy,et al.  Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion-spheronization. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  F. Podczeck,et al.  The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  W. Reilly,et al.  Viscoelastic evaluation of topical creams containing microcrystalline cellulose/sodium carboxymethyl cellulose as stabilizer , 2008, AAPS PharmSciTech.

[15]  H. Lieberman,et al.  Pharmaceutical dosage forms : tablets , 1980 .